Payer+Provider's Health System Review
McKesson will pay $37M to settle suit claiming it fueled West Virginia opioid epidemic
1st cancer-targeting CRISPR clinical trial in US seeks FDA approval
May 3, 2019
Read the full post on Becker's Hospital Review